Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) Short Interest Down 52.0% in August

Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) was the recipient of a large decline in short interest in the month of August. As of August 31st, there was short interest totaling 173,858 shares, a decline of 52.0% from the August 15th total of 362,103 shares. Approximately 0.4% of the shares of the company are short sold. Based on an average daily trading volume, of 247,213 shares, the days-to-cover ratio is currently 0.7 days.

Analysts Set New Price Targets

Separately, Weiss Ratings upgraded shares of Zhengye Biotechnology from a “sell (d-)” rating to a “sell (d)” rating in a research report on Monday, July 20th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Zhengye Biotechnology Trading Down 2.8%

Shares of ZYBT opened at $1.38 on Wednesday. Zhengye Biotechnology has a twelve month low of $0.62 and a twelve month high of $10.84. The firm’s 50 day moving average price is $1.65 and its two-hundred day moving average price is $1.14. The company has a quick ratio of 0.82, a current ratio of 1.14 and a debt-to-equity ratio of 0.03.

Zhengye Biotechnology Company Profile

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.